CML

Advertisement
Rob DillardASCO 2022 | October 16, 2023
Chronic myelomonocytic leukemia (CMML) is a heterogenous blood cancer which exhibits features similar to ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 6, 2023
According to results from the ASCEMBL trial, asciminib was superior to bosutinib in inducing major molecular responses ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 6, 2023
For patients with chronic myeloid leukemia (CML), treatment with tyrosine kinase inhibitors (TKIs) has increased the ...
Rob DillardMDS | August 30, 2023
A study sought to assess whether skin lesions of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia ...
Rob DillardMDS | August 30, 2023
A study identified a modular approach for measuring physical functioning and fatigue in myelodysplastic syndromes (MDS). ...
Rob DillardITP | August 28, 2023
A study assessed the association between immune thrombocytopenia (ITP), and myelodysplastic syndromes (MDS) and chronic ...
DocWire News EditorsOncology | June 7, 2021
A retrospective study published in Cancer Medicine provided real-world data on patients with chronic myelomonocytic ...
DocWire News EditorsOncology | August 30, 2023
A meta-analysis published in Hematology compared hypomethylating agents (HMAs) decitabine versus azaciticine in patients ...
Rebecca AraujoOncology | February 12, 2021
This week on DocWire News, editors spoke with Dr. Jorge Cortes, Director of the Georgia Cancer Center, about the ...
Kaitlyn D’OnofrioOncology | April 10, 2023
Jorge Cortes, MD, Director of the Georgia Cancer Center, talks about the approval of ponatinib for adults with ...
Rob DillardHematology | August 31, 2023
When physicians suspect a diagnosis of certain conditions, a referral to a hematologist is warranted.
Rob DillardOncology | March 31, 2023
Leukemia, which derives from the Greek words leukos (white) and haima (blood) is a form of cancer that affects the blood ...
Kaitlyn D’OnofrioOncology | September 25, 2019
A recent study found evidence supporting the use of dasatinib 50 mg in chronic‐phase chronic myeloid leukemia ...
DocWire News EditorsSOHO 2019 | September 17, 2019
Pregnant patients with chronic myeloid leukemia (CML) should be treated according to major molecular response (MMR) and ...
DocWire News EditorsSOHO 2019 | September 13, 2019
Among Egyptian patients, early identification additional chromosomal abnormalities (ACAs) in Ph+ metaphases in chronic ...
DocWire News EditorsSOHO 2019 | September 12, 2019
Most pretreated patients with Philadelphia chromosome–positive (Ph+ CP) chronic myeloid leukemia experienced confirmed ...
DocWire News EditorsSOHO 2019 | September 12, 2019
Despite significant progress being made in the management of chronic myeloid leukemia (CML) which has allowed many to ...
DocWire News EditorsSOHO 2019 | September 13, 2019
DocWire News will provide coverage of the seventh annual Society of Hematologic Oncology Meeting (SOHO 2019), which will ...
DocWire News EditorsEuropean Society of Hematology 2019 | June 14, 2019
A new study presented by Dr. Ekaterina Chelysheva at the 24th Congress of European Hematology Association (EHA) in ...
Advertisement